VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,936,000 | +8.5% | 13,531 | -0.5% | 0.03% | +3.0% |
Q3 2014 | $1,784,000 | -24.3% | 13,597 | -27.2% | 0.03% | -21.4% |
Q2 2014 | $2,358,000 | +2.0% | 18,689 | +6.5% | 0.04% | -4.5% |
Q1 2014 | $2,312,000 | +29.9% | 17,541 | +15.6% | 0.04% | +51.7% |
Q4 2013 | $1,780,000 | +2.6% | 15,168 | -8.9% | 0.03% | -12.1% |
Q3 2013 | $1,735,000 | +24.0% | 16,643 | +2.1% | 0.03% | +10.0% |
Q2 2013 | $1,399,000 | – | 16,300 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |